EUVIMEDEUVIMED entdecken
Crossref

Immunological Conversion of Solid Tumors Using an Outer Membrane Vesicle Based Checkpoint Nanoinhibitor for Cancer Immunotherapy

Ming Tang, Wei Lv, Xiaoyu Gao, Chen Xu, Tianjiao Zhang, Bingxin Liang, Xiao Zhao iD, Hongli Liao, Chong Du, Xiang Li iD, Keman Cheng iD

ACS Nano · 2026

DOI: 10.1021/acsnano.5c14341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Ming Tang und 10 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience …. Hauptthemen laut MEDLINE: Immunotherapy, Immune Checkpoint Inhibitors, Bacterial Outer Membrane, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Chengdu Science and Technology Bureau, Natural Science Foundation of Beijing Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyImmune Checkpoint InhibitorsBacterial Outer MembraneNeoplasmsAnimalsMicePolyethylene GlycolsTumor MicroenvironmentHumansB7-H1 AntigenNanoparticlesCell Line, TumorFemale

Stichwörter der Autor:innen

OMVscancer immunotherapyimmune checkpoint blockadenanotechnologytumor microenvironment

Substanzen

Polyethylene GlycolsImmune Checkpoint InhibitorsB7-H1 Antigen

Autor:innen und Institutionen

  • CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, No.11 Zhongguancun Beiyitiao, Beijing 100190, China.
  • School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
  • School of Pharmacy, Chengdu Medical College, Chengdu 610500, China.
  • The Comprehensive Breast Care Center, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.

ORCID-Profile: Xiao Zhao, Xiang Li, Keman Cheng

Förderung

  • National Key Research and Development Program of China
  • Chengdu Science and Technology Bureau
  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China
  • Sichuan Provincial Central Leading Local Science and Technology Development Fund Project

Zitieren

APA

Tang, M., Lv, W., Gao, X., Xu, C., Zhang, T., Liang, B., Zhao, X., Liao, H., Du, C., Li, X., & Cheng, K. (2026). Immunological Conversion of Solid Tumors Using an Outer Membrane Vesicle Based Checkpoint Nanoinhibitor for Cancer Immunotherapy. ACS Nano. https://doi.org/10.1021/acsnano.5c14341

Vancouver

Tang M, Lv W, Gao X, Xu C, Zhang T, Liang B, et al. Immunological Conversion of Solid Tumors Using an Outer Membrane Vesicle Based Checkpoint Nanoinhibitor for Cancer Immunotherapy. ACS Nano. 2026. doi:10.1021/acsnano.5c14341

BibTeX
@article{Tang2026,
  author = {Tang, Ming and Lv, Wei and Gao, Xiaoyu and Xu, Chen and Zhang, Tianjiao and Liang, Bingxin and Zhao, Xiao and Liao, Hongli and Du, Chong and Li, Xiang and Cheng, Keman},
  title = {Immunological Conversion of Solid Tumors Using an Outer Membrane Vesicle Based Checkpoint Nanoinhibitor for Cancer Immunotherapy},
  journal = {ACS Nano},
  year = {2026},
  doi = {10.1021/acsnano.5c14341}
}
Kostenlos starten →